Ajanta Pharma Financials
NSE: AJANTPHARM | BSE: 532331
₹3,508.80
₹49.10
(1.42%)
As on 30-Oct-2026IST
Market cap
₹43,891 Cr
Revenue (TTM)
₹6,217 Cr
P/E Ratio
34.8
P/B Ratio
9
Div. Yield
0.8 %
Income Statement (₹ Cr) |
TTM | Mar-26 | Mar-25 | Mar-24 | Mar-23 | Mar-22 | Mar-21 | Mar-20 | Mar-19 | Mar-18 | Mar-17 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Operating Revenue
|
6,216.60
|
5,452.86
|
4,648.10
|
4,208.71
|
3,742.64
|
3,340.99
|
|
|
|
|
|
|
Total Income
|
6,411.29
|
5,624.93
|
4,742.60
|
4,293.31
|
3,841.28
|
3,456.67
|
|
|
|
|
|
|
Total Expenditure
|
4,529.81
|
4,058.03
|
3,388.60
|
3,036.77
|
2,959.39
|
2,411.70
|
|
|
|
|
|
|
EBITDA
|
1,686.79
|
1,394.83
|
1,259.50
|
1,171.94
|
783.25
|
929.29
|
|
|
|
|
|
|
Depreciation
|
180.94
|
173.14
|
144.11
|
135.40
|
130.80
|
125.29
|
|
|
|
|
|
|
EBIT
|
1,505.85
|
1,221.69
|
1,115.39
|
1,036.54
|
652.45
|
804.00
|
|
|
|
|
|
|
Interest
|
12.88
|
16.11
|
20.73
|
7.21
|
5.84
|
10.20
|
|
|
|
|
|
|
Other Income
|
194.69
|
172.07
|
94.50
|
84.60
|
98.64
|
115.68
|
|
|
|
|
|
|
Exceptional Items
|
--
|
--
|
--
|
--
|
--
|
--
|
|
|
|
|
|
|
Profit before Tax
|
1,687.66
|
1,377.65
|
1,189.16
|
1,113.93
|
745.25
|
909.48
|
|
|
|
|
|
|
Provision for Tax
|
424.83
|
321.65
|
268.77
|
297.76
|
157.27
|
196.80
|
|
|
|
|
|
|
Profit after Tax
|
1,262.83
|
1,056.00
|
920.39
|
816.17
|
587.98
|
712.68
|
|
|
|
|
|
|
Minority Interest
|
--
|
--
|
--
|
--
|
--
|
--
|
|
|
|
|
|
|
Share of Associate
|
--
|
--
|
--
|
--
|
--
|
--
|
|
|
|
|
|
|
Consolidated Profit
|
1,262.83
|
1,056.00
|
920.39
|
816.17
|
587.98
|
712.68
|
|
|
|
|
|
Liabilities (₹ Cr) |
TTM | Mar-26 | Mar-25 | Mar-24 | Mar-23 | Mar-22 | Mar-21 | Mar-20 | Mar-19 | Mar-18 | Mar-17 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Shareholder's Funds
|
4,858.27
|
4,527.09
|
3,790.29
|
3,567.36
|
3,387.99
|
3,264.34
|
|
|
|
|
|
|
Minority Interest
|
--
|
--
|
--
|
--
|
--
|
--
|
|
|
|
|
|
|
Non-Current Liabilities
|
224.20
|
32.52
|
42.13
|
40.82
|
177.38
|
285.02
|
|
|
|
|
|
|
Current Liabilities
|
1,342.80
|
1,686.96
|
1,284.98
|
895.25
|
1,139.28
|
647.39
|
|
|
|
|
|
|
Total Liabilities
|
6,425.27
|
6,317.22
|
5,193.31
|
4,529.89
|
4,704.65
|
4,196.75
|
|
|
|
|
|
Assets (₹ Cr) |
TTM | Mar-26 | Mar-25 | Mar-24 | Mar-23 | Mar-22 | Mar-21 | Mar-20 | Mar-19 | Mar-18 | Mar-17 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Non-Current Assets
|
2,373.25
|
2,239.93
|
1,985.49
|
1,773.02
|
1,870.65
|
1,932.29
|
|
|
|
|
|
|
Current Assets
|
3,823.28
|
4,006.64
|
3,118.58
|
2,722.07
|
2,825.18
|
2,264.46
|
|
|
|
|
|
|
Total Assets
|
6,425.27
|
6,317.22
|
5,193.31
|
4,529.89
|
4,704.65
|
4,196.75
|
|
|
|
|
|
|
Total Debt*
|
--
|
211.99
|
2.59
|
1.49
|
1.43
|
1.91
|
|
|
|
|
|
|
Net Current Assets
|
2,480.48
|
2,319.68
|
1,833.60
|
1,826.82
|
1,685.90
|
1,617.07
|
|
|
|
|
|
|
Contingent Liabilities
|
--
|
8.12
|
8.12
|
4.42
|
4.03
|
6.76
|
|
|
|
|
|
Cashflow (₹ Cr) |
TTM | Mar-26 | Mar-25 | Mar-24 | Mar-23 | Mar-22 | Mar-21 | Mar-20 | Mar-19 | Mar-18 | Mar-17 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Cash From Operating Activities
|
--
|
529.19
|
1,157.23
|
785.07
|
792.11
|
561.71
|
|
|
|
|
|
|
Cash Flow from Investing Activities
|
--
|
-428.92
|
-376.52
|
65.39
|
-559.60
|
-74.10
|
|
|
|
|
|
|
Cash from Financing Activities
|
--
|
-167.92
|
-733.41
|
-1,051.06
|
-108.20
|
-459.71
|
|
|
|
|
|
|
Net Cash Inflow / Outflow
|
--
|
-67.65
|
47.30
|
-200.60
|
124.31
|
27.90
|
|
|
|
|
|
Financials Ratios |
TTM | Mar-26 | Mar-25 | Mar-24 | Mar-23 | Mar-22 | Mar-21 | Mar-20 | Mar-19 | Mar-18 | Mar-17 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Adjusted EPS (₹)
|
101.07
|
84.55
|
73.69
|
64.83
|
46.70
|
55.63
|
|
|
|
|
|
|
Cash EPS (₹)
|
101.06
|
98.41
|
85.23
|
75.58
|
57.09
|
65.42
|
|
|
|
|
|
|
Adjusted Book Value (₹)
|
388.78
|
362.19
|
303.04
|
282.89
|
269.07
|
254.80
|
|
|
|
|
|
|
Dividend per Share (₹)
|
0.80
|
28.00
|
28.00
|
51.00
|
7.00
|
9.50
|
|
|
|
|
|
|
Cash Flow per Share (₹)
|
--
|
42.37
|
92.65
|
62.36
|
62.92
|
65.77
|
|
|
|
|
|
|
Free Cash Flow per Share (₹)
|
--
|
16.90
|
74.10
|
55.55
|
48.54
|
57.23
|
|
|
|
|
|
Profitability Ratios |
TTM | Mar-26 | Mar-25 | Mar-24 | Mar-23 | Mar-22 | Mar-21 | Mar-20 | Mar-19 | Mar-18 | Mar-17 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
ROCE (%)
|
--
|
32.67
|
32.87
|
32.22
|
22.57
|
29.37
|
|
|
|
|
|
|
ROE (%)
|
26.91
|
25.42
|
25.06
|
23.49
|
17.68
|
22.77
|
|
|
|
|
|
|
ROA (%)
|
20.88
|
18.59
|
19.13
|
17.73
|
13.21
|
17.16
|
|
|
|
|
|
|
EBIT Margin (%)
|
24.22
|
22.40
|
24.00
|
24.63
|
17.43
|
24.06
|
|
|
|
|
|
|
Net Margin (%)
|
19.70
|
18.77
|
19.41
|
19.01
|
15.31
|
20.62
|
|
|
|
|
|
|
Cash Profit Margin (%)
|
--
|
10.88
|
11.96
|
11.93
|
10.03
|
24.68
|
|
|
|
|
|
Growth Ratios |
TTM | Mar-26 | Mar-25 | Mar-24 | Mar-23 | Mar-22 | Mar-21 | Mar-20 | Mar-19 | Mar-18 | Mar-17 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Revenue Growth (%)
|
25.01
|
17.31
|
10.44
|
12.45
|
12.02
|
15.62
|
|
|
|
|
|
|
EBIT Growth (%)
|
32.42
|
9.53
|
7.61
|
58.87
|
-18.85
|
-8.89
|
|
|
|
|
|
|
Net Profit Growth (%)
|
29.70
|
14.73
|
12.77
|
38.81
|
-17.50
|
8.99
|
|
|
|
|
|
|
EPS Growth (%)
|
29.70
|
14.73
|
13.67
|
38.81
|
-16.06
|
10.40
|
|
|
|
|
|
|
Book Value Growth (%)
|
--
|
19.52
|
6.27
|
5.14
|
3.79
|
8.98
|
|
|
|
|
|
Valuation Ratios |
TTM | Mar-26 | Mar-25 | Mar-24 | Mar-23 | Mar-22 | Mar-21 | Mar-20 | Mar-19 | Mar-18 | Mar-17 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Price / Earnings
|
34.76
|
33.16
|
35.53
|
34.52
|
25.89
|
14.45
|
|
|
|
|
|
|
Price / Book Value
|
9.03
|
7.74
|
8.64
|
7.91
|
4.49
|
4.73
|
|
|
|
|
|
|
Dividend Yield (%)
|
0.80
|
1.00
|
1.07
|
2.28
|
0.58
|
0.53
|
|
|
|
|
|
|
EV/EBITDA
|
23.33
|
22.42
|
24.03
|
22.32
|
16.89
|
14.58
|
|
|
|
|
|
|
Close Price (₹)
|
3,620.80
|
2,805.10
|
2,623.00
|
2,230.85
|
1,208.80
|
1,207.17
|
|
|
|
|
|
|
High Price (₹)
|
3,796.95
|
3,228.00
|
3,485.75
|
2,355.05
|
1,427.50
|
1,623.33
|
|
|
|
|
|
|
Low Price (₹)
|
2,379.30
|
2,022.05
|
2,049.75
|
1,154.70
|
1,061.77
|
1,088.07
|
|
|
|
|
|
|
Market Cap (₹ Cr)
|
43,890.61
|
35,015.54
|
32,704.96
|
28,177.73
|
15,220.57
|
15,450.14
|
|
|
|
|
|
Solvency Ratios |
TTM | Mar-26 | Mar-25 | Mar-24 | Mar-23 | Mar-22 | Mar-21 | Mar-20 | Mar-19 | Mar-18 | Mar-17 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Debt to Equity
|
--
|
0.05
|
0.00
|
0.00
|
0.00
|
0.00
|
|
|
|
|
|
|
Short term debt to equity ratio
|
--
|
0.05
|
--
|
--
|
--
|
--
|
|
|
|
|
|
|
Current Ratio
|
2.85
|
2.38
|
2.43
|
3.04
|
2.48
|
3.50
|
|
|
|
|
|
|
Quick Ratio
|
2.13
|
1.82
|
1.73
|
2.12
|
1.77
|
2.31
|
|
|
|
|
|
|
Interest Coverage
|
132.03
|
86.52
|
58.36
|
155.50
|
128.61
|
90.16
|
|
|
|
|
|
Operating Efficiency Ratios |
TTM | Mar-26 | Mar-25 | Mar-24 | Mar-23 | Mar-22 | Mar-21 | Mar-20 | Mar-19 | Mar-18 | Mar-17 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Debtors to sales (%)
|
29.98
|
34.00
|
25.45
|
29.63
|
28.24
|
30.52
|
|
|
|
|
|
|
Asset Turnover
|
1.03
|
1.99
|
1.85
|
1.73
|
1.61
|
0.82
|
|
|
|
|
|
|
Receivable days
|
--
|
49.07
|
49.80
|
52.69
|
52.87
|
94.50
|
|
|
|
|
|
|
Inventory Days
|
--
|
29.77
|
35.51
|
37.60
|
40.91
|
83.71
|
|
|
|
|
|
|
Payable days
|
--
|
183.00
|
187.66
|
183.71
|
157.44
|
188.77
|
|
|
|
|
|
|
Cash Conversion Cycle
|
--
|
-104.16
|
-102.34
|
-93.41
|
-63.66
|
-10.56
|
|
|
|
|
|
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
loading...
loading...
loading...
loading...
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.
